ESR1 and invasive ductal breast carcinoma: Most tumors were invasive ductal carcinoma (N= 18, 81.8%), pathological stage I (N= 9, 40.9%), grade I (N= 10, 45.5%), and estrogen-receptor (ER) positive (N= 21, 95.4%, Supplementary Table 1).